Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

$2.31 Bn Competent Cells Market - Global Opportunity Analysis and Industry Forecast 2018-2023 -

Research and Markets
Posted on: 08 Mar 18

The "Competent Cells Market - Global Opportunity Analysis and Industry Forecast (2018-2023)" report has been added to's offering

"Global competent cells market is expected to reach USD 2,318.6 million by 2023, at a CAGR of 10.0% during the forecast period of 2018 to 2023."

Growing demand for recombinant proteins and molecular cloned products, advancement in molecular cloning research with emergence of new technologies, and various government initiatives and availability of funding for life science research are the key drivers propelling the industry growth during the forecast period. Moreover, emerging economies such as Latin America, Asia Pacific, & Africa provides significant opportunity in this market. However, factors such as high cost of cloning based research and shortage of skilled professionals for handling of competent cells hinder the growth of this market in many parts of the globe.

Transformation is a process which includes direct uptake of DNA released into an environment by host cells and simultaneously integrates that DNA with host genome for recombination. Naturally, many bacteria have an ability to take up DNA from environment. The DNA provides nutrients to these natural competent cells, while recombination leads to new genetic evolution.

This ability to take up external DNA is referred as natural competence. However, not all bacteria are naturally competent; thereby reduces the chances of recombinational development. Hence, by using this concept, researchers developed artificial competence, where the cells are made competent using induced methods such as electroporation or chemicals mediated methods.

Scope of the report

Market by Type:

  • Cloned Competent Cells
  • Agrobacterium tumefaciens Competent Cells
  • Expression Competent Cells

Market by Treatment:

  • Chemically Competent Cells
  • Electrocompetent Cells

Market by Application:

  • Cloning
  • Subcloning & Routine Cloning
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Phage Display Library production
  • Protein Expression
  • Others
  • Single Stranded DNA Preparation
  • Mutagenesis Study
  • Large Plasmid Transformation
  • Lentiviral Vector Production

Market by End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Applications, Inc.
  • Delphi Genetics S.A.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Merck & Co., Inc.
  • Meridian Bioscience, Inc.
  • New England Biolabs
  • OriGene Technologies, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Scarab Genomics, LLC
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp

For more information about this report visit

View source version on

Business Wire

Last updated on: 08/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.